Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma

References

• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. Ca A Cancer J Clinicians. 2015;60(5):277–300.
   Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. Ca A Cancer J Clinicians. 2016;66(4):271–289.
   PubMed Web of Science ®Google Scholar
• Delaine-Smith RM, Reilly GC. Chapter twenty – the effects of mechanical loading on mesenchymal stem cell differentiation and matrix production. Vitamins Hormones. 2011;87(10):417.
   PubMedGoogle Scholar
• Drummond SN, De MLIA, Barbosa AA, et al. TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res. 2002;22(6A):3379–3381.
   PubMed Web of Science ®Google Scholar
• Farazi TA, Hoell JI, Morozov P, et al. microRNAs in human cancer. Adv Exp Med Biol. 2013;774(2):1–20.
   PubMed Web of Science ®Google Scholar
• Betel D, Wilson M, Gabow A, et al. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36(Database issue):149–153.
   PubMed Web of Science ®Google Scholar
• Song Z, Li G. Role of specific MicroRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury. J Cardiovasc Transl Res. 2010;3(3):246.
   PubMed Web of Science ®Google Scholar
• Sadat AAS, Hossein GSM. The role of microRNAs in cardiovascular disease. Int J Mole Cell Med. 2013;2(2):50–57.
   PubMedGoogle Scholar
• Ghisi M, Corradin A, Basso K, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood. 2011;117(26):7053–7062.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Hanazawa T, Nohata N, et al. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways. J Hum Genet. 2012;57(9):556–563.
   PubMed Web of Science ®Google Scholar
• Sun T, Wang Q, Balk S, et al. The role of microRNA-221 and −222 in Androgen-independent prostate cancer cell lines. Cancer Res. 2009;69(8):3356.
   PubMed Web of Science ®Google Scholar
• Takahashi RU, Miyazaki H, Ochiya T. The roles of MicroRNAs in breast cancer. Cancers (Basel). 2015;7(2):598.
   PubMed Web of Science ®Google Scholar
• Tang H, Wu Z, Zhang J, et al. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013;7(3):761–766.
   PubMed Web of Science ®Google Scholar
• Severino P, Oliveira LS, Andreghetto FM, et al. Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma. BMC Med Genomics. 2015;8(1):1–15.
   PubMedGoogle Scholar
• Manikandan M, Rao AKDM, Arunkumar G, et al. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer. 2016;15(1):28.
   PubMedGoogle Scholar
• Lee WM. The myc family of nuclear proto-oncogenes. Cancer Treat Res. 1989;47:37–71.
   PubMedGoogle Scholar
• Brenner C, Deplus R, Didelot C, et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. Embo J. 2014;24(2):336–346.
   Google Scholar
• Koskinen PJ, Alitalo K. Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol. 1993;4(1):3–12.
   PubMed Web of Science ®Google Scholar
• Ishizaki H, Yano H, Tsuneoka M, et al. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol Int. 2010;57(10):672–680.
   Google Scholar
• Mai S. Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase. Gene. 1994;148(2):253–260.
   PubMed Web of Science ®Google Scholar
• Pai R, Pai S, Lalitha R, et al. Over-expression of c-Myc oncoprotein in oral squamous cell carcinoma in the South Indian population. Ecancermedicalscience. 2009;3(1):128.
   PubMedGoogle Scholar
• Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar GD, et al. What real influence does the proto-oncogene c-myc have in OSCC behavior? Oral Oncol. 2011;47(8):688–692.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang J, Zhao H, et al. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy. Arch Biochem Biophys. 2015;580::84–92.
   Web of Science ®Google Scholar
• He XY, Chen JX, Zhang Z, et al. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer Res Clin Oncol. 2010;136(7):1023–1028.
   PubMed Web of Science ®Google Scholar
• Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, et al. Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim (NY). 2013;42(6):217–224.
   PubMed Web of Science ®Google Scholar
• Xu XH, Zhang SJ, Hu QB, et al. Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway. J Cell Biochem. 2019;120(2):2594–2606.
   Google Scholar
• Qiaoli Z, Assimopoulou AN, Klauck SM, et al. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells. Oncotarget. 2015;6(36):38934–38951.
   PubMedGoogle Scholar
• Saeed NR, Gold JA. Oral squamous cell carcinoma. BMJ. 1994;308(6936):1103.
   Google Scholar
• Zhang B, Pan X, Cobb GP, et al. microRNAs as oncogenes and tumor suppressors. N Engl J Med. 2007;302(1):1–12.
   Google Scholar
• Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006;25(46):6188–6196.
   PubMed Web of Science ®Google Scholar
• Siow MY, Ng LPK, Abraham MT, et al. P132. MicroRNA profiles of oral squamous cell carcinoma (OSCC) using formalin-fixed, paraffin embedded (FFPE) tissue. Oral Oncol. 2011;47(Suppl 1):S117–S117.
   Google Scholar
• Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol. 2008;18(10):505–516.
   PubMed Web of Science ®Google Scholar
• Iwasaki T, Tanaka K, Kawano M, et al. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells. Int J Oncol. 2015;46(4):1543–1550.
   PubMed Web of Science ®Google Scholar
• Yukihiro A, Yoshihito N, Tomoki N. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull. 2006;29(5):903.
   PubMed Web of Science ®Google Scholar
• Sampson VB, Rong NH, Han J, et al. MicroRNA Let-7a Down-regulates MYC and reverts MYC-Induced growth in Burkitt Lymphoma Cells. Cancer Res. 2007;67(20):9762–9770.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cheng N, Luo J. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma. J Biochem Mole Toxicolo. 2017;31(7):e21904.
   Web of Science ®Google Scholar
• Dang C. MYC on the Path to Cancer. Cell. 2012;149(1):22–35.
   PubMed Web of Science ®Google Scholar
• Grandori C, Cowley SMJames LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior[Review]. Annu Rev Cell Dev Biol. 2000;16(1):653.
   PubMedGoogle Scholar
• Stine ZE, Walton ZE, Altman BJ, et al. MYC, metabolism, and cancer. Cancer Discov. 2015;5(10):1024.
   PubMed Web of Science ®Google Scholar
• Lin C, Lovén J, Rahl P, et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell. 2012;151(1):56–67.
   PubMed Web of Science ®Google Scholar
• Nie Z, Hu G, Wei G, et al. c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells. Cell. 2012;151(1):68–79.
   PubMed Web of Science ®Google Scholar
• Susanne W, Francesca L, Jennifer M, et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature. 2014;511(7510):483–487.
   PubMed Web of Science ®Google Scholar
• Boxer RB, Jang JW, Sintasath L, et al. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell. 2004;6(6):577–586.
   PubMed Web of Science ®Google Scholar
• Welm AL, Suwon K, Welm BE. MET and MYC cooperate in mammary tumorigenesis. Proc Natl Acad Sci U S A. 2005;102(12):4324–4329.
   PubMed Web of Science ®Google Scholar
• Hong L, Radisky DC, Dun Y, et al. MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat Cell Biol. 2012;14(6):567.
   PubMed Web of Science ®Google Scholar
• Lin X, Sun R, Zhao X, et al. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling. J Mol Med (Berl). 2017;95(1):53–67.
   PubMed Web of Science ®Google Scholar